US Stock MarketDetailed Quotes

Estrella Immunopharma (ESLA)

Watchlist
  • 1.660
  • -0.070-4.05%
Close Apr 16 15:59 ET
  • 1.660
  • 0.0000.00%
Post 16:10 ET
70.82MMarket Cap-4.74P/E (TTM)

Estrella Immunopharma (ESLA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
42.65%-1.79M
39.12%-177.49K
82.82%-727.33K
-414.88K
-465.98K
-133.03%-3.11M
-574.10%-291.51K
-4,914.13%-4.23M
-10,313.48%-11.27M
74.99%-275.19K
Net income from continuing operations
-195.09%-13.06M
84.48%-613.17K
-922.54%-4.8M
---5.54M
---2.1M
60.17%-4.43M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
Operating gains losses
--38.19K
---28.85K
----
----
----
----
----
----
----
----
Depreciation and amortization
----
----
----
----
----
----
----
--0
----
----
Change In working capital
1,105.19%10.62M
-91.36%316.18K
202.37%3.85M
--4.97M
--1.48M
-90.59%881.25K
40.73%3.66M
-247.72%-3.77M
-503.91%-10.25M
-76.19%400.65K
-Change in prepaid assets
122.28%431.19K
-97.12%104.23K
93.35%-232.97K
--358.86K
--201.07K
-332.21%-1.94M
7,134.70%3.62M
-6,909.72%-3.5M
---262.48K
--0
-Change in payables and accrued expense
261.80%10.19M
402.13%211.95K
1,670.59%4.09M
--4.61M
--1.28M
-67.00%2.82M
-98.35%42.21K
-110.02%-260.24K
-493.66%-9.98M
-52.81%400.65K
-Change in other current liabilities
----
----
----
----
----
----
----
--0
----
----
Cash from discontinued investing activities
Operating cash flow
42.65%-1.79M
39.12%-177.49K
82.82%-727.33K
---414.88K
---465.98K
-133.03%-3.11M
-574.10%-291.51K
-4,914.13%-4.23M
-10,313.48%-11.27M
74.99%-275.19K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
5.07M
-112.3K
Net other investing changes
----
----
----
----
----
----
--0
--0
--5.07M
---112.3K
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
--0
--0
--0
--5.07M
---112.3K
Financing cash flow
Cash flow from continuing financing activities
1,769.11%2.25M
76.02%-64.82K
1,333.60%1.04M
1.31M
-29.46K
-134.99K
-270.35K
-84.09K
-6.9M
20.05M
Net issuance payments of debt
----
----
----
----
----
--0
--0
--0
---300K
--300K
Net common stock issuance
1,856.14%2.37M
--0
--1.05M
--1.35M
---29.46K
---134.99K
---270.35K
----
----
--0
Net preferred stock issuance
----
----
----
----
----
--0
--0
--0
--0
--9.02M
Net other financing activities
---117.47K
---64.82K
---12.65K
----
----
----
--0
--0
---6.6M
--10.73M
Cash from discontinued financing activities
Financing cash flow
1,769.11%2.25M
76.02%-64.82K
1,333.60%1.04M
--1.31M
---29.46K
---134.99K
---270.35K
---84.09K
---6.9M
--20.05M
Net cash flow
Beginning cash position
-77.99%916.92K
-65.59%1.63M
-85.45%1.32M
--421.47K
--916.92K
1.89%4.17M
77.79%4.73M
214.11%9.05M
640.87%22.14M
-39.36%2.48M
Current changes in cash
114.39%467.39K
56.87%-242.31K
107.18%310.02K
--895.12K
---495.44K
-101.87%-3.25M
-212.53%-561.86K
-1,854.29%-4.32M
-12,000.24%-13.09M
1,886.80%19.66M
End cash Position
50.97%1.38M
-66.77%1.38M
-65.59%1.63M
--1.32M
--421.47K
-63.01%916.92K
68.02%4.17M
77.79%4.73M
214.11%9.05M
640.87%22.14M
Free cash flow
42.65%-1.79M
39.12%-177.49K
82.82%-727.33K
---414.88K
---465.98K
-133.03%-3.11M
-574.10%-291.51K
-4,914.13%-4.23M
-10,313.48%-11.27M
74.99%-275.19K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 42.65%-1.79M39.12%-177.49K82.82%-727.33K-414.88K-465.98K-133.03%-3.11M-574.10%-291.51K-4,914.13%-4.23M-10,313.48%-11.27M74.99%-275.19K
Net income from continuing operations -195.09%-13.06M84.48%-613.17K-922.54%-4.8M---5.54M---2.1M60.17%-4.43M-44.65%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M
Operating gains losses --38.19K---28.85K--------------------------------
Depreciation and amortization ------------------------------0--------
Change In working capital 1,105.19%10.62M-91.36%316.18K202.37%3.85M--4.97M--1.48M-90.59%881.25K40.73%3.66M-247.72%-3.77M-503.91%-10.25M-76.19%400.65K
-Change in prepaid assets 122.28%431.19K-97.12%104.23K93.35%-232.97K--358.86K--201.07K-332.21%-1.94M7,134.70%3.62M-6,909.72%-3.5M---262.48K--0
-Change in payables and accrued expense 261.80%10.19M402.13%211.95K1,670.59%4.09M--4.61M--1.28M-67.00%2.82M-98.35%42.21K-110.02%-260.24K-493.66%-9.98M-52.81%400.65K
-Change in other current liabilities ------------------------------0--------
Cash from discontinued investing activities
Operating cash flow 42.65%-1.79M39.12%-177.49K82.82%-727.33K---414.88K---465.98K-133.03%-3.11M-574.10%-291.51K-4,914.13%-4.23M-10,313.48%-11.27M74.99%-275.19K
Investing cash flow
Cash flow from continuing investing activities 0005.07M-112.3K
Net other investing changes --------------------------0--0--5.07M---112.3K
Cash from discontinued investing activities
Investing cash flow ----------------------0--0--0--5.07M---112.3K
Financing cash flow
Cash flow from continuing financing activities 1,769.11%2.25M76.02%-64.82K1,333.60%1.04M1.31M-29.46K-134.99K-270.35K-84.09K-6.9M20.05M
Net issuance payments of debt ----------------------0--0--0---300K--300K
Net common stock issuance 1,856.14%2.37M--0--1.05M--1.35M---29.46K---134.99K---270.35K----------0
Net preferred stock issuance ----------------------0--0--0--0--9.02M
Net other financing activities ---117.47K---64.82K---12.65K--------------0--0---6.6M--10.73M
Cash from discontinued financing activities
Financing cash flow 1,769.11%2.25M76.02%-64.82K1,333.60%1.04M--1.31M---29.46K---134.99K---270.35K---84.09K---6.9M--20.05M
Net cash flow
Beginning cash position -77.99%916.92K-65.59%1.63M-85.45%1.32M--421.47K--916.92K1.89%4.17M77.79%4.73M214.11%9.05M640.87%22.14M-39.36%2.48M
Current changes in cash 114.39%467.39K56.87%-242.31K107.18%310.02K--895.12K---495.44K-101.87%-3.25M-212.53%-561.86K-1,854.29%-4.32M-12,000.24%-13.09M1,886.80%19.66M
End cash Position 50.97%1.38M-66.77%1.38M-65.59%1.63M--1.32M--421.47K-63.01%916.92K68.02%4.17M77.79%4.73M214.11%9.05M640.87%22.14M
Free cash flow 42.65%-1.79M39.12%-177.49K82.82%-727.33K---414.88K---465.98K-133.03%-3.11M-574.10%-291.51K-4,914.13%-4.23M-10,313.48%-11.27M74.99%-275.19K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More